Robert Barrow, CEO: Definium Therapeutics DFTX Sell · Filed 06/26

Trade details

Type: Insider sale
Amount: $1,315,236.24
Shares · price: 29,208 sh · $45.03 a share
Held after: 1,098,246 sh
Stock: Definium Therapeutics DFTX
Person: Robert BarrowCEO
Trade date: 26/06/25
Filed: 26/06/26
Days to filing: 1 days

Sold 2.6% of holdings

Share of holding sold: 2.6%

Definium Therapeutics trades, last 26 weeks

What else happened in Definium Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Robert Barrow's recent trades

Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/29
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
31,550 sh
$1.2M
Filed 09/25
Traded 09/25
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$718.1K
19,023 sh
$718.1K
Filed 09/03
Traded 09/03
Robert BarrowCEO
Planned saleDefinium Therapeutics
Planned sale
Definium Therapeutics
DFTX
$1.2M
29,208 sh
$1.2M
Filed 06/25
Traded 06/25
Robert BarrowCEO
Sell10b5-1 planDefinium Therapeutics
Sell10b5-1 plan
Definium Therapeutics
DFTX
$451.2K
24,431 sh
$451.2K
Filed 03/26
Traded 03/25